Published in Vaccine Weekly, January 3rd, 2007
Pathogen-free cells are critical for the rapid development of cell-culture-based vaccine production to help protect against the spread of influenza viruses among humans, including potentially the high-pathogenicity H5N1 avian flu virus.
"I'm very pleased that independent lab tests have confirmed our PBS-1 cells are pathogen-free. This is especially good news for HepaLife's researchers, who can now confidently accelerate our...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.